Cargando…
BAD sensitizes breast cancer cells to docetaxel with increased mitotic arrest and necroptosis
Breast cancer patients are commonly treated with taxane (e.g. docetaxel) chemotherapy, despite poor outcomes and eventual disease relapse. We previously identified the Bcl-2-associated death promoter (BAD) as a prognostic indicator of good outcome in taxane-treated breast cancer patients. We also de...
Autores principales: | Mann, Jasdeep, Yang, Ning, Montpetit, Rachel, Kirschenman, Raven, Lemieux, Hélène, Goping, Ing Swie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962214/ https://www.ncbi.nlm.nih.gov/pubmed/31942016 http://dx.doi.org/10.1038/s41598-019-57282-1 |
Ejemplares similares
-
Non-canonical BAD activity regulates breast cancer cell and tumor growth via 14-3-3 binding and mitochondrial metabolism
por: Mann, Jasdeep, et al.
Publicado: (2019) -
Photo-activation of the delocalized lipophilic cation D112 potentiates cancer selective ROS production and apoptosis
por: Yang, Ning, et al.
Publicado: (2017) -
BAD regulates mammary gland morphogenesis by 4E-BP1-mediated control of localized translation in mouse and human models
por: Githaka, John Maringa, et al.
Publicado: (2021) -
Lysophosphatidate Induces Chemo-Resistance by Releasing Breast Cancer Cells from Taxol-Induced Mitotic Arrest
por: Samadi, Nasser, et al.
Publicado: (2011) -
The Rubella Virus Capsid Is an Anti-Apoptotic Protein that Attenuates the Pore-Forming Ability of Bax
por: Ilkow, Carolina S., et al.
Publicado: (2011)